News Demant A/S Börse Stuttgart

Equities

Real-time Estimate Tradegate Other stock markets 04:00:14 2024-07-17 am EDT			5-day change	1st Jan Change
35.57 ^EUR	-9.58%		-1.16%	-0.66%

06:53am	Demant Cuts FY24 Organic Growth Guidance	MT
Jun. 26	Demant Flags Delay in Completion of Communications Business' Strategic Review	MT

Demant Cuts FY24 Organic Growth Guidance	12:53am	MT
Demant A/S: Revised financial outlook for 2024 and preliminary H1 financial key figures	Jul. 16	AQ
Demant Flags Delay in Completion of Communications Business' Strategic Review	Jun. 26	MT
Demant A/S: Updated timeline for the strategic review of Communications	Jun. 26	AQ
UK’s Competition Regulator Closes Cochlear-Demant Deal	May. 29	MT
Denmark's Demant Completes Sale of Cochlear Implants Business	May. 21	MT
Demant A/S: Closing of divestment of cochlear implants business	May. 21	AQ
Cochlear Limited acquired Oticon Medical A/s from Demant A/S.	May. 20	CI
DEMANT : Q1 sales miss; organic growth guidance unchanged	May. 06
Transcript : Demant A/S, Q1 2024 Interim Management Statement Call, May 06, 2024	May. 06
Hearing Healthcare Company Demant Affirms FY24 Outlook	May. 06	MT
Demant A/S: Interim Management Statement for Q1 2024	May. 06	AQ
Demant A/S Provides Earnings Guidance for the Year 2024	May. 06	CI
Denmark's Demant Finalizes Capital Reduction	Apr. 08	MT
Demant A/S: Completion of capital reduction in Demant A/S	Apr. 08	AQ
Competition Regulator Clears Cochlear’s Acquisition of Oticon Medical’s Cochlear Implant Business	Apr. 03	MT
Demant Seeks Acquisitions	Mar. 12	CI
Transcript : Demant A/S - Analyst/Investor Day	Mar. 12
Demant A/S: Capital Markets Day 2024 - Sharpened focus on Hearing Healthcare	Mar. 12	AQ
Demant A/S: Decisions of Annual General Meeting	Mar. 06	AQ

No results for this search

DEMANT : Q1 sales miss; organic growth guidance unchanged

May 06, 2024 at 11:18 am EDT